Ultrasound technology to control the spatial organization of cells and proteins in engineered tissues

• US 10,640,750 B2
• Filed: 05/26/2017
• Issued: 05/05/2020
• Est. Priority Date: 05/19/2009
• Status: Active Grant

• Current Assignee: University of Rochester
• Original Assignee: University of Rochester
• Inventors: Dalecki, Diane, Hocking, Denise, Garvin, Kelley
• Primary Examiner(s): Bowers, Erin M.
• Application Number:
  US15/606,828
• Publication Number:
  US 20170260504A1
• Time in Patent Office: 1,075 Days
• Field of Search: None
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: A61K 9/00 Medicinal preparations characterised by special physical form nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations A61K49/18; preparations containing radioactive substances A61K51/12
• CPC Class Codes: C12M 35/04 Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
• CPC Class Codes: C12N 13/00 Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
• CPC Class Codes: C12N 2521/10 Sound, e.g. ultrasounds
• CPC Class Codes: C12N 2533/52 Fibronectin; Laminin
• CPC Class Codes: C12N 2533/54 Collagen; Gelatin
• CPC Class Codes: C12N 5/0062 General methods for three-dimensional culture
• CPC Class Codes: C12N 5/0656 Adult fibroblasts
• CPC Class Codes: C12N 5/069 Vascular Endothelial cells
• CPC Class Codes: C12Q 1/02 involving viable microorganisms
• CPC Class Codes: C12Q 1/68 involving nucleic acids

Abstract

The present invention is directed to methods of inducing spatial organization of cells an in vitro culture system using ultrasound technology. The invention is further directed to methods of inducing extracellular matrix remodeling and neovessel formation in an in vitro culture system and generating vascularized engineered tissue constructs using ultrasound technology.

Claims

1. An in vitro vascularized engineered tissue construct, wherein said construct has a thickness in three-dimensions of at least 2 mm, said construct comprising:

a polymerized biological support material comprising one or more recombinant fibronectin peptide mimetics;

endothelial cells organized into two or more three-dimensional sheets or columns within different planes of said polymerized biological support material; and

lumen containing neovessels defined by said endothelial cells, said lumen containing neovessels extending within and/or between said three-dimensional sheets or columns of endothelial cells.

2. The vascularized engineered tissue construct of claim 1, wherein the biological support material is selected from the group consisting of collagen gel, fibrin gel, hydrogel, growth factor reduced Matrigel, and Matrigel.

3. The vascularized engineered tissue construct of claim 1, wherein said construct further comprises a three-dimensional biological support material selected from the group consisting of filaments, meshes, foams, gels, ceramics, a porous polymeric scaffold, a synthetic polymeric scaffold, and acellularized extracellular matrix material.

4. The vascularized engineered tissue construct of claim 1, wherein lumen-containing neovessels originate from one of the three-dimensional sheets or columns of endothelial cells and interconnect with lumen-containing neovessels that originate from a different three-dimensional sheet or column of endothelial cells.

5. The vascularized engineered tissue construct of claim 1, wherein said lumen-containing neovessels have internal diameters of 0.5 mm or less.

6. The vascularized engineered tissue construct of claim 1, wherein said construct further comprises one or more additional cell type.

7. The vascularized engineered tissue construct of claim 6, wherein the one or more additional cell type is selected from the group consisting of smooth muscle cells, cardiac muscle cells, cardiac myocytes, platelets, epithelial cells, urothelial cells, fibroblasts, embryonic fibroblasts, myoblasts, chondrocytes, chondroblasts, osteoblasts, osteoclasts, keratinocytes, hepatocytes, bile duct cells, pancreatic islet cells, thyroid, parathyroid, adrenal, hypothalamic, pituitary, ovarian, testicular, salivary gland cells, adipocytes, embryonic stem cells, mesenchymal stem cells, neural cells, endothelial progenitor cells, hematopoietic cells, and precursor cells.

8. The vascularized engineered tissue construct of claim 7, wherein the one or more additional cell type is neural cells.

9. The vascularized engineered tissue construct of claim 1, wherein said construct comprises a vascularized muscular construct, a vascularized esophageal construct, a vascularized intestinal construct, a vascularized rectal construct, a vascularized ureteral construct, a vascularized cartilaginous construct, a vascularized cardiac construct, a vascularized liver construct, a vascularized bladder construct, a vascularized kidney construct, a vascularized pancreatic construct, a vascularized skeletal construct, a vascularized filamentous/ligament construct, a vascularized lung construct, a vascularized neural construct, a vascularized bone construct, or a vascularized skin construct.

10. The vascularized engineered tissue construct of claim 9, wherein said construct comprises a vascularized neural construct.

11. A method of treating a subject in need of a tissue repair or tissue replacement, said method comprising:

selecting a subject in need of tissue repair or tissue replacement;

providing the vascularized engineered tissue construct of claim 1; and

implanting the vascularized engineered tissue construct into a region of the selected subject in need of tissue repair or tissue replacement.

12. The method of claim 11, wherein the subject is in need of neural tissue repair or replacement.

13. The method of claim 11, wherein the vascularized engineered tissue construct is a vascularized engineered neural tissue construct.

14. The method of claim 11, wherein the vascularized engineered tissue construct comprises endothelial cells obtained from the selected subject.

15. The method of claim 11, wherein the subject is a human subject.